AIA - CA19.9 near me in Ajmer

The AIA - CA19.9 is designed to detect potential cancer and monitor the treatment effectiveness. It measures the level of cancer antigen 19.9, a glycoprotein that can be elevated in certain cancers and other medical conditions. It is most commonly used as a tumor marker for pancreatic cancer. Elevated CA19.9 levels may also be seen in cancers of the bile ducts, gallbladder, or gastrointestinal tract. Its levels can also rise in non-cancerous conditions, such as pancreatitis, gallstones, liver disease, and bile duct inflammation. For individuals diagnosed with pancreatic or related cancers, the CA19.9 test is often used to monitor response to treatment and assess disease progression or recurrence. Tracking changes in CA19.9 levels over time provides valuable insights into how the condition is evolving, helping guide ongoing care decisions. This test serves as an important tool for understanding overall health and the effect of treatment on cancer.

Disclaimer: Tumor markers (e.g., CA 19.9) are specialized tests that should not be used alone for cancer diagnosis due to potential false positives and negatives. They are most useful for monitoring high-risk patients, tracking disease progression, and assessing treatment response. They are unsuitable for vague symptoms or general screening because of their lack of specificity and potential elevation in benign conditions. Additionally, some procedures can temporarily raise tumor marker levels, so consult your doctor about the best timing for these tests.